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Introduction
Dobutamine stress cardiovascular magnetic resonance
(DCMR) is a robust tool for determining the presence
of inducible ischaemia in patients with known or sus-
pected coronary artery disease (CAD).
Purpose
To assess the safety of DCMR in clinical practice in a
tertiary referral centre in the UK.
Methods
We retrospectively studied all DCMR scans performed
between May 2006 and March 2009.
CMR Protocol
CMR studies were performed using a 1.5 T (Siemens
Avanto) clinical CMR scanner. After a full functional
assessment using steady state free precession (SSFP) cine
imaging, three short axis images together with the three
long axis (2-, 3- and 4- chamber) images were selected
and these were then acquired at each dose increment
during a standard dobutamine-atropine protocol. Dobu-
tamine was infused in 10 mcg/ kg/ min increments up to
a maximum of 40 mcg/ kg/ min. Initial 5 mcg/ kg/ min
increments were used where there was a wall motion
abnormality at rest. The protocol was continued until
target heart rate was achieved or until there was a recog-
nised indication to stop prior to reaching target heart
rate. Side effects and complications were recorded.
Results
Out of 455 patients, 21(4.6%) patients were unable to
undergo the procedure (claustrophobia, MR incompati-
ble device in situ)
434 scans were performed in patients with a mean age
of 64 years (range 13-86). 419 patients had a full dose
study to assess for inducible ischaemia while 15 patients
had a low dose protocol to determine myocardial
viability.
The average dose of dobutamine required for each full
dose study was 24 + 9 micrograms/ kg/ min with addi-
tional atropine used in 119 (27.4%) patients. Target
heart rate was achieved in 334 (79%) patients.
Of the 85 patients who failed to achieve target heart
rate, 37(43%) developed significant chest pain, requiring
the infusion to be stopped. Chest pain was the common-
est cardiac side effect but in only 20% of these patients
was the scan stopped early. 5 patients needed in-patient
overnight observation for hypotension (2), broad complex
tachycardia (1) and fast AF (2). None of these had a sig-
nificant rise in troponin.
Minor non-cardiac side effects occurred in 18 (4%)
patients (eg nausea).
Conclusions
Our experience suggests DCMR is a safe and feasible
technique in routine clinical practice for assessing
patients with suspected or known CAD and has a low
complication rate.
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